FDA Releases Guidance on Public Availability of Advisory Committee Members' Financial Interest Information and Waivers

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining procedures for the public, advisory committee members, and FDA staff to access and understand information about advisory committee members' financial interests and waivers, effective October 2007.